Peloton Wealth Strategists
Position in NBIX — Neurocrine Biosciences Inc
CIK 1080132
INDIANAPOLIS, IN
Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,441,301
+$684,549 QoQ
Shares Held
14,485
+8.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#289
of 768 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Peloton Wealth Strategists holds $4,394,455 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (55.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
14,485 | $2,441,301 | |
| 2 | ZTS |
Zoetis Inc.
|
27,180 | $1,953,154 |
All Filings in NBIX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,441,301 | 14,485 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,756,752 | 13,335 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,923,214 | 13,560 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,938,647 | 13,810 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,874,037 | 14,910 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,657,894 | 14,990 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $1,926,697 | 14,115 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $404,998 | 3,515 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||